rdf:type |
|
lifeskim:mentions |
umls-concept:C0003339,
umls-concept:C0005953,
umls-concept:C0017262,
umls-concept:C0018957,
umls-concept:C0019764,
umls-concept:C0038250,
umls-concept:C0054943,
umls-concept:C0185117,
umls-concept:C0229664,
umls-concept:C1261322,
umls-concept:C1332710,
umls-concept:C1439292,
umls-concept:C1998793,
umls-concept:C2911684
|
pubmed:issue |
1
|
pubmed:dateCreated |
1993-9-2
|
pubmed:abstractText |
We evaluated the HLA-DR, CD33 and CD13 antigen expression on CD34+ haematopoietic progenitor cells (HPC) isolated from the bone marrow (BM) and peripheral blood (PB) of normal donors. The majority of both BM and PB CD34+ HPC expressed CD13 and HLA-DR. The coexpression of CD34 and CD33 was found in a minor CD34+ subset. After 7 d of culture in the presence of interleukin-3 and granulocyte-macrophage colony-stimulating factor, CD33 expression was detected in about 50% of HPC. At this point CD34 antigen expression was lost and CD13 and HLA-DR expression was partially lost. After 14 d of culture, the majority of HPC were CD33+. HPC maintained the capacity to generate colony forming unit granulocyte-macrophage but they lost the capacity to generate burst forming unit-erythroid. A correlation was found between the percentage of CD34+/HLA-DR+ cells and the total number of colony forming cells in unfractionated samples from BM and PB of patients with malignancies. These studies demonstrate that, in normal conditions, only a minor subset of CD34+ cells coexpress CD33 antigen either in BM or in PB and CD33 antigen is a lineage marker which is coexpressed with HLA-DR and CD13 on a progenitor committed to the granulocytic-macrophagic lineage.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD13,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/CD33 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte-Macrophage...,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-3
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0007-1048
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
24-30
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7687858-Antigens, CD,
pubmed-meshheading:7687858-Antigens, CD13,
pubmed-meshheading:7687858-Antigens, CD34,
pubmed-meshheading:7687858-Antigens, Differentiation, Myelomonocytic,
pubmed-meshheading:7687858-Antigens, Neoplasm,
pubmed-meshheading:7687858-Bone Marrow,
pubmed-meshheading:7687858-Cell Differentiation,
pubmed-meshheading:7687858-Cell Division,
pubmed-meshheading:7687858-Cells, Cultured,
pubmed-meshheading:7687858-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:7687858-HLA-DR Antigens,
pubmed-meshheading:7687858-Hematopoietic Stem Cells,
pubmed-meshheading:7687858-Humans,
pubmed-meshheading:7687858-Interleukin-3
|
pubmed:year |
1993
|
pubmed:articleTitle |
Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
|
pubmed:affiliation |
Servizio di Ematologia ed Emotransfusione, Catholic University, Rome.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|